Triple valve replacement after recurrent infective endocarditis and previous COVID-19 infection
The authors present redo mitral valve replacement, aortic valve and tricuspid valve replacement in a patient with recurrent infective endocarditis following COVID-19 infection. This patient with EuroSCORE II 19.24% underwent successful triple valve replacement.
Authors
- Ya.A. Aidamirov (ORCID: https://orcid.org/0000-0003-3870-1040)
- E.P. Evseev
- V.A. Ivanov (ORCID: https://orcid.org/0000-0001-6277-0375)
- A.A. Botashev (ORCID: https://orcid.org/0000-0002-1224-3224)
- D.A. Podchasov (ORCID: https://orcid.org/0000-0003-4500-2344)
- E.V. Balakin (ORCID: https://orcid.org/0000-0002-9658-6725)
- E.V. Ivanova
Institutions
- Russian Scientific Center of Surgery (RU)
Publication Details
- Journal
- Pirogov Russian Journal of Surgery
- Published
- 2025-12-25
- DOI
- https://doi.org/10.17116/hirurgia2025112104
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00